Management of Persistent Bacteremia Caused by Methicillin‐ResistantStaphylococcus aureus:A Survey of Infectious Diseases Consultants
Author(s) -
Jeffrey Hageman,
Laura A. Liedtke,
Rebecca Sunenshine,
Larry J. Strausbaugh,
L. Clifford McDonald,
Fred C. Tenover
Publication year - 2006
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/506568
Subject(s) - bacteremia , medicine , staphylococcus aureus , methicillin resistant staphylococcus aureus , antimicrobial , vancomycin , intensive care medicine , staphylococcal infections , microbiology and biotechnology , antibiotics , bacteria , biology , genetics
We conducted a survey in 2005 of infectious diseases consultants and asked about persistent bacteremia due to methicillin-resistant Staphylococcus aureus. Many consultants perceived an increase in the frequency of illness, and, when presented with vancomycin minimum inhibitory concentrations approaching the limit of the susceptible range, most consultants indicated that they would switch to newer antimicrobial agents for treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom